Simplified Selection Criteria for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer

Simplified Selection Criteria for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer

(1) Background: Multiple confounding factors influence the indications for secondary cytoreductive surgery (SCS) in patients with ovarian cancer (OC). We aimed to identify the factors associated with patients most likely to benefit from SCS. (2) Methods: We retrospectively reviewed the medical recor...

Full description

Bibliographic Details
Main Authors:	Joo-Hyuk Son, Jimin Lee, Sun-Hyung Yum, Jeeyeon Kim, Tae-Wook Kong, Suk-Joon Chang, Hee-Sug Ryu
Format:	Article
Language:	English
Published:	MDPI AG 2022-08-01
Series:	Cancers
Subjects:	advanced ovarian cancer recurrent ovarian cancer secondary cytoreductive surgery
Online Access:	https://www.mdpi.com/2072-6694/14/16/3987

Similar Items

Significance of cholecystectomy in cytoreductive surgery for advanced ovarian cancer
by: Joo-Hyuk Son, et al.
Published: (2023-03-01)

Hepatic Hilar Lymph Node Resection in Cytoreductive Surgery for Advanced Ovarian Cancer: A Necessity or Not?
by: Huang H, et al.
Published: (2021-10-01)

Quaternary and beyond cytoreduction: An updated and expanded analysis
by: Beryl L. Manning-Geist, et al.
Published: (2021-08-01)

Prediction of suboptimal cytoreductive surgery in patients with advanced ovarian cancer based on preoperative and intraoperative determination of the peritoneal carcinomatosis index
by: Antoni Llueca, et al.
Published: (2018-02-01)

Chemokine Ligand 5 to Predict Optimal Cytoreduction in Ovarian Cancer
by: Hidayat YM, et al.
Published: (2020-11-01)

Clinical Utility of Preoperative Assessment in Ovarian Cancer Cytoreduction
by: Pratistha Koirala, et al.
Published: (2020-08-01)

Evaluation of staging, cytoreduction and second-look operation of 119 ovarian cancer patients
by: Eddie Fernando Candido Murta, et al.

Surgical outcomes of ureteral reconstruction during cytoreductive surgery for ovarian cancer: a retrospective cohort study
by: Ji Hyun Kim, et al.
Published: (2022-11-01)

Cytoreductive Surgery with the PlasmaJet Improved Quality-of-Life for Advanced Stage Ovarian Cancer Patients
by: Gatske M. Nieuwenhuyzen-de Boer, et al.
Published: (2023-08-01)

Microbiological monitoring in patients with advanced ovarian cancer before and after cytoreductive surgery – a preliminary report
by: Szymankiewicz Maria, et al.
Published: (2017-12-01)

Comparative study of quality of life, adverse effects after cytoreduction and HIPEC in stage IIIA-IIIC ovarian cancer
by: A. I. Rybin, et al.
Published: (2018-10-01)

Comparative study of quality of life, adverse effects after cytoreduction and HIPEC in stage IIIA-IIIC ovarian cancer
by: A. I. Rybin, et al.
Published: (2018-10-01)

Advances in Cytoreductive Surgery and Combination Therapy for Ovarian Cancer
by: Xiaolan Lv, et al.
Published: (2022-07-01)

Splenectomy as Part of Maximal-Effort Cytoreductive Surgery in Advanced Epithelial Ovarian Cancer
by: Vasilios Pergialiotis, et al.
Published: (2024-02-01)

Nomogram to predict postoperative complications after cytoreductive surgery for advanced epithelial ovarian cancer: A multicenter retrospective cohort study
by: Caixia Jiang, et al.
Published: (2022-11-01)

Pancreaticoduodenectomy in optimal primary cytoreduction of epithelial ovarian cancer: A case report and review of the literature
by: Joy M. Beissel, et al.
Published: (2014-12-01)

Laparoscopy and computed tomography imaging in advanced ovarian tumors: A roadmap for prediction of optimal cytoreductive surgery
by: Ahmed Samy El-Agwany
Published: (2018-01-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer
by: Loss Martin, et al.
Published: (2004-06-01)

Survival Impact of Secondary Cytoreductive Surgery for Recurrent Ovarian Cancer in an Asian Population
by: Rani Akhil Bhat, et al.
Published: (2015-09-01)

Robotic-assisted interval cytoreductive surgery in ovarian cancer: a feasibility study
by: Semiramis L. Carbajal-Mamani, et al.
Published: (2020-03-01)

The ability of whole-body SUVmax in F-18 FDG PET/CT to predict suboptimal cytoreduction during primary debulking surgery for advanced ovarian cancer
by: Gun Oh. Chong, et al.
Published: (2019-02-01)

Secondary surgical cytoreduction needs to be assessed taking into account surgical technique, completeness of cytoreduction, and extent of disease
by: Juan José Segura-Sampedro, et al.
Published: (2020-05-01)

Survival impact of bowel resection at the time of interval cytoreductive surgery for advanced ovarian cancer
by: Blair McNamara, et al.
Published: (2021-11-01)

Combined Interval Cytoreductive Surgery and Carboplatin-Based Hyperthermic Intraperitoneal Chemotherapy in Advanced Primary High-Grade Serous Ovarian Cancer
by: Claudèle Brault, et al.
Published: (2023-12-01)

Prognostic Significance of Preoperative NLR, MLR, and PLR Values in Predicting the Outcome of Primary Cytoreductive Surgery in Serous Epithelial Ovarian Cancer
by: Anna Rebeka Kovács, et al.
Published: (2023-07-01)

Explainable Artificial Intelligence for Prediction of Complete Surgical Cytoreduction in Advanced-Stage Epithelial Ovarian Cancer
by: Alexandros Laios, et al.
Published: (2022-04-01)

Relationship Between Neoadjuvant Chemotherapy and Log Odds of Positive Lymph Nodes and Their Prognostic Role in Advanced Ovarian Cancer Patients With Optimal Cytoreductive Surgery
by: Yue-min Hou, et al.
Published: (2022-05-01)

Survival impact and safety of intrathoracic and abdominopelvic cytoreductive surgery in advanced ovarian cancer: a systematic review and meta-analysis
by: Jiaxi Wang, et al.
Published: (2024-01-01)

Predicting incomplete cytoreduction in patients with advanced ovarian cancer
by: Eva K. Egger, et al.
Published: (2022-12-01)

The role of CA-125, GLS and FASN in predicting cytoreduction for epithelial ovarian cancers
by: G. N. A. Winarno, et al.
Published: (2020-07-01)

A New Paradigm in Managing Advanced Ovarian Cancer: Differentiating Patients Requiring Neoadjuvant Treatment from Primary Cytoreduction
by: Francois Kraus, et al.
Published: (2021-09-01)

Cytoreductive Surgery (CRS) and HIPEC for Advanced Ovarian Cancer with Peritoneal Metastases: Italian PSM Oncoteam Evidence and Study Purposes
by: Daniele Marrelli, et al.
Published: (2022-12-01)

Impact of prehabilitation during neoadjuvant chemotherapy and interval cytoreductive surgery on ovarian cancer patients: a pilot study
by: Ester Miralpeix, et al.
Published: (2022-02-01)

Cytoreductive surgery including distal pancreatectomy with splenectomy in advanced stage ovarian cancer: Two centers analysis
by: Anil Erturk, et al.
Published: (2020-11-01)

3D laparoscopy as a tertiary cytoreductive (TCR) surgery in infiltrating ureter recurrent epithelial ovarian cancer – case report and a mini-review of the literature
by: Tomasz Szopiński, et al.
Published: (2018-12-01)

Predicting complete cytoreduction for advanced ovarian cancer patients using nearest-neighbor models
by: Alexandros Laios, et al.
Published: (2020-09-01)

The role of cytoreduction surgery in advanced ovarian cancer (review)
by: R K Tandelov, et al.
Published: (2018-03-01)

Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Epithelial Ovarian Cancer: A 20-Year Single-Center Experience
by: Fabio Carboni, et al.
Published: (2021-01-01)

Predictive significance of preoperative CT findings for suboptimal cytoreduction in advanced ovarian cancer: a meta-analysis
by: Hu TWY, et al.
Published: (2018-07-01)

Surgical outcome prediction in patients with advanced ovarian cancer using computed tomography scans and intraoperative findings
by: Ha-Jeong Kim, et al.
Published: (2014-09-01)